Subscribe for stories that matter!
Kannalife Sciences, a subsidiary of Neuropathix, Inc., was awarded a $2.97 million grant from the National Institutes of Health’s National Institute of Neurological…
Neuropathix, Inc., a pain management life sciences company in Doylestown, has appointed pharmaceutical industry veteran Michael Ropacki, PhD, to its scientific advisory board.
Ropacki is…
Before we send you to , pleasesubscribe to our daily newsletter.